Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001
about
Tuberculosis: current situation, challenges and overview of its control programs in IndiaIsoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsIncidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysisDevelopment of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studiesEffect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.AIDS-related tuberculosis in Rio de Janeiro, Brazil.The HIV-Brazil cohort study: design, methods and participant characteristics.Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan AfricaAntiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.In-hospital mortality of disseminated tuberculosis in patients infected with the human immunodeficiency virus.Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysisOutcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008.Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.Antiretroviral therapy for tuberculosis control in nine African countries.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.Epidemiology of HIV-associated tuberculosis.Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infectionThe proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review.Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionA Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan AfricaTuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic.Pathogenesis of HIV and the lungCost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.High rates of tuberculosis in patients accessing HAART in rural South Africa.Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.
P2860
Q24603827-E36789C3-1CB9-4B8F-ACF3-9B1F3D0AF41CQ26778385-09997E87-EC90-4A85-8CDE-822E7D4E7B11Q27012753-CD689597-ED4F-40BF-8886-1DC61F745CC5Q28743478-0F56B576-568B-4E89-850C-6DD74D114F78Q30240445-649DFBF9-0C7D-49AB-A47A-3B0452DEC718Q33368050-DC16FA43-47CF-4AFB-BEFC-20C215161124Q33553184-B5785B69-1BFD-4B82-97BC-371BAFB74A53Q33580153-4FBFAB08-E29E-4E7C-81D7-3CC5531EC4D5Q33920318-8F9FD766-BF70-489A-B537-F1AB5BC03764Q34089192-6D2071A3-D0A6-4DD0-8C48-DA29FAC9678AQ34146085-BD66CE62-1576-44B7-8E0B-0F4026CF7C5EQ34211754-6E51A49C-3520-4A03-9CB9-2A3E2C1B843AQ34213437-D1D2918A-1E6A-49CA-87E3-D98A71DBDC95Q34320245-5606563E-CA50-4B2D-8EC1-B21F87DC4F00Q34387168-33D7E5F4-A149-4A1D-8FD1-DED65CFB776CQ34499835-585F17CB-FED8-49BB-930A-B4AD6C83ADA6Q34519940-08AFFC92-3003-4BAC-A3C0-A46193CCF7E4Q34532773-6660981E-4EA1-40BC-80B5-44B66CC5881FQ34649281-A266A3CE-CC78-4C6A-A4F0-BD0AC3082CDBQ34802722-BEFF90AE-7E94-4754-B18A-36C5D96EFE4CQ34914625-02F62500-6392-4625-ACE7-2EE169F3B68EQ35514622-FD8C8D10-21E2-4890-8B1E-13A37FAF4A0AQ35870509-41740F13-0722-4101-9FFE-205E1A288DF9Q36082304-D4D29C9C-2FD6-40C7-BFFD-D9DCCF815527Q36479517-96CD27B0-493C-4E0B-B96B-AAF54758EA26Q36509003-31A2B5D8-A424-4848-9147-606682769FD6Q36594970-8C97FB0A-B215-472C-928F-0BEEFFE1567EQ36950190-24C722CE-CCE7-42DB-B9A7-7EE63A0AAF89Q37461125-59D1C966-C9F2-493E-AE2B-972EA43C7616Q37465373-7800D31F-A573-4393-9E63-79C21D6A6CCAQ37619616-4163AD02-C440-4A65-A6C0-B2995E12F290Q37626250-A3951C1C-9D0A-4534-9AB3-950B47D094BDQ38107500-E749CE93-AA43-4986-9ACB-29CD520DA5E4Q38855709-9F6B157D-B697-4E06-9088-A6F355343BC0Q42364307-105ADF92-5D2F-4838-BA72-2CDF24E967FBQ45233459-77E20CC6-C53F-4AAF-B7CE-7F91C1B940BDQ47641918-DBECEAFD-9A3F-4B9F-8B7B-D3C098E403BC
P2860
Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@ast
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@en
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@nl
type
label
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@ast
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@en
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@nl
prefLabel
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@ast
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@en
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@nl
P2093
P2860
P1433
P1476
Impact of antiretroviral thera ...... razilian experience, 1995-2001
@en
P2093
Abraham Miranda
Charles Wells
Denise Garrett
Draurio Barreira
Guida Silva
Joseney Santos
Kayla Laserson
Leda Jamal
Meade Morgan
Patricia Paine
P2860
P356
10.1371/JOURNAL.PONE.0000826
P407
P577
2007-09-05T00:00:00Z